Mark A. Glickman - Oct 15, 2021 Form 3 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Chief Business Officer
Signature
/S/ Mark A. Glickman
Stock symbol
TXMD
Transactions as of
Oct 15, 2021
Transactions value $
$0
Form type
3
Date filed
10/15/2021, 05:15 PM
Next filing
Mar 28, 2022

No securities are beneficially owned.